FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
104 letters match. Newest first.
-
Food100Misterios, LDA
Portuguese canner 100Misterios' seafood safety plans and sardine canning process controls fall short, FDA says
High risk -
FoodWaiakea Bottling Inc.
FDA warned Waiakea Bottling that ineffective water treatment and weak process controls led to microbial contamination in bottled water.
High risk -
DrugsAnuMed International, LLC
FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.
High risk -
DrugsEyePoint Pharmaceuticals, Inc.
FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.
High risk -
BiologicsBerkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.
FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.
High risk -
DrugsYangZhou SuXiang Medical Instrument Co., Ltd.
FDA warns YangZhou SuXiang Medical Instrument over manufacturing quality failures and import alert for OTC drugs.
High risk -
DrugsMax Chemical Inc.
FDA warned Max Chemical Inc. in San Juan, Puerto Rico, that its OTC drug manufacturing violated CGMP, making its drugs adulterated.
High risk -
DrugsARG Laboratories, Inc.
FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.
High risk -
DrugsArt of Beauty Company, Inc.
FDA warned Art of Beauty over manufacturing-rule violations in OTC hand sanitizer, including missing component and finished-product testing.
High risk -
FoodTamara Fruit CJSC
FDA warns Tamara Fruit CJSC that its juice nectars and acidified Imam-Bayaldi are adulterated after inspection found HACCP and recordkeeping failures.
High risk -
DrugsAqualex Co., Ltd.
Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.
High risk -
DrugsSafari Stem Cell, LLC
FDA warned Safari Stem Cell for selling unapproved stem cell animal drugs made without required CGMP controls, including sterility testing.
High risk -
FoodSwity d.o.o.
FDA warned Swity d.o.o. over acidified yellow pepper fillets made outside its filed process, with inadequate corrective response.
High risk -
FoodHacienda Mexican Foods, LLC
FDA warns Hacienda Mexican Foods of Salmonella risk and missing controls in ready-to-eat tortillas.
High risk -
FoodHunan Gagazui Food Co., Ltd.
Hunan Gagazui Food Co., Ltd. processed U.S.-bound low-acid canned surimi soybean snacks outside its filed process and without required retort controls.
High risk -
DrugsC&T Dream Co., Ltd.
C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.
High risk -
DrugsMaster Paints & Chemicals Corp.
FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.
High risk -
FoodKitchen Garden Foods, LTD
FDA warned Kitchen Garden Foods that its exported acidified chutneys lacked filed processes and required controls.
Medium -
DrugsBodywell Natural Skin Care Inc.
FDA warned Bodywell Natural Skin Care that its OTC hand sanitizer and Dermalere creams were adulterated due to CGMP failures and unapproved drug claims.
High risk -
DrugsThai Nakorn Patana Co., Ltd.
FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.
High risk -
DrugsColgin, Inc.
FDA warned Colgin that its OTC drug ChigaRid External Analgesic violated manufacturing quality rules, including expired ingredients and missing tests.
High risk -
DrugsQuVa Pharma, Inc.
FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.
High risk -
FoodReConserve Inc.
FDA warned ReConserve Inc. that animal-food ingredients stored outdoors uncovered were contaminated and its preventive controls were inadequate.
High risk -
BiologicsMiMedx Group, Inc.
FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.
High risk -
DevicesDeymed Diagnostic s.r.o.
Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.
Medium -
DrugsDextrum Laboratories Inc.
FDA found Dextrum Laboratories, an over-the-counter drug contract manufacturer, failed identity testing, toxic glycol checks, water monitoring, and process validation.
High risk -
DrugsColonial Dames Company, Ltd
FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.
High risk -
DrugsBrenntag Great Lakes, LLC
Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.
High risk -
DrugsLex Inc.
FDA warns Lex Inc. of Medley, Florida, that its over-the-counter drugs are adulterated because manufacturing rules were not met, including missing toxic-ingredient testing.
High risk -
FoodReckitt/Mead Johnson Nutrition
FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.
High risk -
FoodByHeart, Inc.
FDA warns ByHeart that Cronobacter contamination in infant formula and weak investigations led to release of adulterated powdered formula.
High risk -
FoodPerrigo Wisconsin, LLC
FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.
High risk -
FoodSTC India Private Limited
FDA warned STC India over insanitary conditions and missing Salmonella controls for ready-to-eat mukhwas.
High risk -
DrugsBaxter Healthcare Corporation
FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.
High risk -
DrugsRemedyRepack, Inc.
RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.
High risk -
DevicesNorth American Diagnostics, LLC
FDA warns North American Diagnostics over unapproved COVID-19 antigen tests and quality system failures.
High risk -
FoodOld Europe Cheese, Inc.
Old Europe Cheese's ready-to-eat Brie and Camembert were tied to a six-state Listeria outbreak and made under insanitary conditions.
High risk -
DrugsCosmetic Science Laboratories LLC
FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.
High risk -
DrugsFormology Lab Inc.
FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.
High risk -
DrugsProfounda, Inc.
FDA warns Profounda about manufacturing quality failures for over-the-counter drugs, including process validation, stability, water system, and glycerin testing.
High risk -
DrugsB & J Group
B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.
High risk -
DrugsGascó Industrial Corporation
FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.
High risk -
DrugsDelta Kozmetik Sanayi Ve Ticaret-Selim Yesil
FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.
High risk -
DrugsShuzy Rock Inc.
FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.
High risk -
DrugsSystem Kosmetik Produktionsgesellschaft fur kosmetische Gmbh
German OTC drug maker System Kosmetik was cited for manufacturing quality violations, including missing process and cleaning validation.
High risk -
DrugsBioiberica, SAU
FDA warned Bioiberica over unvalidated rework and missing stability testing of API batches at its Spain plant.
High risk -
DrugsColorful Products Corporation
FDA warned Colorful Products Corporation about serious current good manufacturing practice (CGMP) failures for its over-the-counter topical drugs and hand sanitizers.
High risk -
DrugsFroggy’s Fog LLC
FDA warns Froggy’s Fog that its OTC hand sanitizer was made under inadequate CGMP and mislabeled for alcohol strength.
High risk -
DrugsThe W.S. Badger Company, Inc.
FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.
High risk -
DrugsDr Retter Ec Wladyslaw Retter
FDA warns Dr Retter Ec Wladyslaw Retter over manufacturing failures for homeopathic drug cream.
High risk